Takuji Suzuki Selected Research

Sigma-1 Receptor

1/2022

Comments to "Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists" by Khani and Entezari-Maleki.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takuji Suzuki Research Topics

Disease

24	Pulmonary Alveolar Proteinosis 06/2024 - 04/2008
23	Neoplasms (Cancer) 04/2024 - 07/2002
14	COVID-19 04/2024 - 01/2021
11	Inflammation (Inflammations) 06/2024 - 03/2003
10	Respiratory Insufficiency (Respiratory Failure) 04/2024 - 03/2009
8	Infections 06/2022 - 10/2009
7	Lung Neoplasms (Lung Cancer) 02/2024 - 05/2008
7	Pneumonia (Pneumonitis) 02/2024 - 08/2008
7	Lung Diseases (Lung Disease) 01/2022 - 10/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 07/2006
6	Lung Injury 03/2024 - 12/2021
6	Pulmonary Hypertension 01/2024 - 04/2022
5	Hypoxia (Hypoxemia) 07/2023 - 06/2008
5	Leukemia 06/2008 - 01/2005
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2024 - 10/2011
4	Fibrosis (Cirrhosis) 03/2024 - 02/2007
4	Disease Progression 02/2024 - 01/2019
4	Obesity 07/2023 - 10/2011
3	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2024 - 08/2008
3	Dyspnea (Shortness of Breath) 02/2024 - 01/2023
3	Autoimmune Diseases (Autoimmune Disease) 11/2014 - 03/2009
2	Fever (Fevers) 02/2024 - 05/2022
2	Edema (Dropsy) 12/2023 - 01/2023
2	Breast Neoplasms (Breast Cancer) 11/2023 - 04/2021
2	Thymoma (Thymic Carcinoma) 11/2023 - 10/2023
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 07/2022
2	Pulmonary Arterial Hypertension 07/2023 - 05/2022
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
2	Carcinogenesis 01/2023 - 04/2014
2	Acute Lung Injury 10/2022 - 01/2020
2	Sarcoidosis (Schaumann Disease) 01/2022 - 03/2021
2	Colorectal Neoplasms (Colorectal Cancer) 04/2021 - 08/2008
2	Lymphadenopathy 03/2021 - 03/2020
2	Carcinoma (Carcinomatosis) 10/2011 - 01/2005
2	Hepatitis 02/2007 - 10/2005
2	Melanoma (Melanoma, Malignant) 04/2006 - 01/2005

Drug/Important Bio-Agent (IBA)

21	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 04/2008
14	Surface-Active Agents (Surfactants)IBA 06/2024 - 08/2008
9	TeaIBA 01/2023 - 02/2005
7	AutoantibodiesIBA 04/2024 - 03/2009
7	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 01/2022 - 04/2008
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2014
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2005
5	LipopolysaccharidesIBA 03/2024 - 03/2003
4	Matrix Metalloproteinases (MMPs)IBA 03/2024 - 01/2020
4	CytokinesIBA 03/2024 - 07/2002
4	Catechin (Z 7300)IBA 06/2020 - 10/2005
4	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2019 - 03/2009
4	Calcitriol (Calcijex)FDA LinkGeneric 06/2008 - 01/2005
3	AntibodiesIBA 06/2024 - 04/2024
3	SteroidsIBA 12/2023 - 01/2021
3	Immune Checkpoint InhibitorsIBA 12/2023 - 06/2022
3	Fluvoxamine (Luvox)FDA LinkGeneric 02/2022 - 01/2022
3	LipidsIBA 01/2020 - 07/2010
3	Secretory Leukocyte Peptidase InhibitorIBA 04/2014 - 03/2003
3	DNA (Deoxyribonucleic Acid)IBA 06/2008 - 06/2006
2	pembrolizumabIBA 04/2024 - 07/2023
2	nintedanibIBA 03/2024 - 12/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 01/2023
2	indium-bleomycinIBA 01/2024 - 01/2023
2	Oxygen (Dioxygen)IBA 12/2023 - 07/2022
2	Gemcitabine FDA Link 12/2023 - 01/2022
2	AntigensIBA 11/2023 - 01/2005
2	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 07/2006
2	N-(2-cyanoethylene)urea (BA 1)IBA 08/2023 - 01/2022
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 08/2023 - 01/2022
2	ZincIBA 07/2023 - 01/2023
2	Metalloproteases (Metalloproteinases)IBA 07/2023 - 01/2023
2	LigandsIBA 07/2023 - 05/2004
2	Tyrosine Kinase InhibitorsIBA 07/2023 - 08/2008
2	Semaxinib (SU5416)IBA 07/2023 - 05/2022
2	osimertinibIBA 07/2023 - 01/2022
2	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2023 - 01/2021
2	Vasodilator Agents (Vasodilators)IBA 01/2023 - 07/2022
2	DiureticsIBA 01/2023 - 01/2023
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 05/2022
2	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 05/2022 - 01/2021
2	InterleukinsIBA 01/2022 - 01/2005
2	Epidermal Growth Factor (EGF)IBA 01/2022 - 08/2008
2	Interleukin-8 (Interleukin 8)IBA 01/2022 - 01/2005
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	Small Interfering RNA (siRNA)IBA 12/2021 - 04/2014
2	Transcription Factors (Transcription Factor)IBA 06/2015 - 06/2008
2	Urethane (Ethyl Carbamate)IBA 04/2014 - 05/2008
2	Messenger RNA (mRNA)IBA 07/2010 - 07/2002
2	ErbB Receptors (EGF Receptor)IBA 08/2008 - 07/2006
2	Gefitinib (Iressa)FDA Link 08/2008 - 07/2006
2	Karyopherins (Importin)IBA 06/2008 - 04/2006
2	Interleukin-3 (Interleukin 3)IBA 04/2008 - 04/2008
2	GalactosamineIBA 02/2007 - 10/2005
2	Cholecalciferol (Vitamin D3)FDA Link 04/2006 - 01/2005

Therapy/Procedure

9	Therapeutics 06/2024 - 05/2005
8	Transplantation 06/2024 - 10/2014
6	Drug Therapy (Chemotherapy) 12/2023 - 07/2006
3	Lung Transplantation 04/2024 - 01/2022
3	Immunotherapy 04/2006 - 05/2004
2	Radiotherapy 02/2024 - 01/2023
2	Endarterectomy (Thromboendarterectomy) 07/2023 - 04/2022
2	Aftercare (After-Treatment) 01/2022 - 05/2005